Beam Therapeutics Inc. (BEAM) Stock Price

30.61 ▲ +2.27 (+8.01%)
Open: 28.92 Vol: 3.78K Day's range: 28.92 - 30.61 Aug 25, 10:46 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
BEAM Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 30.77▲ 30.12▲ 29.40▲ 29.34▲ 28.13▲
MA10 30.56▲ 29.33▲ 29.12▲ 28.04▲ 29.56▲
MA20 30.06▲ 29.12▲ 29.08▲ 27.43▲ 29.96▲
MA50 29.15▲ 28.88▲ 27.95▲ 29.92▲ 27.68▲
MA100 28.92▲ 27.83▲ 27.52▲ 29.74▲ 24.93▲
MA200 29.09▲ 27.52▲ 27.03▲ 28.23▲ 27.71▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.079▲ 0.262▲ 0.089▲ 0.571▲ -0.299▼
RSI 83.141▲ 73.919▲ 67.809▲ 60.934▲ 54.408▲
STOCH 92.605▲ 65.677     42.231     74.487     21.552    
WILL %R -0.637▲ -0.350▲ -0.344▲ -0.183▲ -52.244    
CCI 163.496▲ 183.273▲ 186.588▲ 184.922▲ 1.980    
Latest Filters Detected On BEAM
▲ MACD $BEAM MACD(12,26,9) Crossed Above Zero Set Alert
MA $BEAM Price Crossed Above MA(50) Set Alert
▲ GAP $BEAM Open Gap Up %2 Set Alert
▲ BREAK $BEAM Price Breaks 20 Days High Set Alert
▲ BREAK $BEAM Price Breaks 10 Days High Set Alert
CDL $BEAM Marubozu Candlestick Pattern Detected Set Alert
Beam Therapeutics Inc. News
Beam Therapeutics to Present Updated Data from Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) in Late-Breaking Oral Presentation at the European ...
Wednesday, July 22, 2026 11:59 PM
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated clinical data from the ...
Is Beam Therapeutics Inc. (BEAM) One of the Best Genomics Stocks to Buy According to Analysts?
Tuesday, June 16, 2026 05:53 AM
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics?
Monday, May 25, 2026 05:36 PM
The medicine should see significant commercial momentum in the next few years. Meanwhile, CRISPR Therapeutics has important pipeline candidates. To name just one: The company's CTX310 is being ...
BEAM historical stock data
date open high low close volume
25/08/26 29.02 31.17 28.92 31.16 531,251
24/08/26 29.22 29.275 28.26 28.34 1,046,874
21/08/26 28.74 30.50 28.61 29.76 2,447,428
20/08/26 28.08 29.08 27.00 28.39 2,408,966
19/08/26 28.20 29.16 27.64 29.07 2,975,714
18/08/26 26.12 26.93 26.00 26.57 1,193,853
17/08/26 26.52 27.24 26.445 27.10 1,468,258
14/08/26 26.64 26.88 25.71 26.75 1,222,628
13/08/26 27.265 27.4888 26.26 26.51 2,002,063
12/08/26 27.00 27.29 26.62 26.71 1,550,822
Quote Details
52wk Low:16.02
52wk High:38.26
Vol:3.78K
Avg Vol(3m):42.1M
1Y Chng:+44.59%
1M Chng:+1.04%
Add to Watch List
More Information
Index US Composite
Market Cap. 2.93B